Bas Oldenburg

17.4k total citations · 2 hit papers
208 papers, 7.7k citations indexed

About

Bas Oldenburg is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Bas Oldenburg has authored 208 papers receiving a total of 7.7k indexed citations (citations by other indexed papers that have themselves been cited), including 139 papers in Genetics, 101 papers in Epidemiology and 58 papers in Surgery. Recurrent topics in Bas Oldenburg's work include Inflammatory Bowel Disease (137 papers), Microscopic Colitis (89 papers) and Colorectal Cancer Screening and Detection (30 papers). Bas Oldenburg is often cited by papers focused on Inflammatory Bowel Disease (137 papers), Microscopic Colitis (89 papers) and Colorectal Cancer Screening and Detection (30 papers). Bas Oldenburg collaborates with scholars based in Netherlands, United States and Germany. Bas Oldenburg's co-authors include Peter D. Siersema, C. Janneke van der Woude, Maurice Lutgens, M.E.I. Schipper, G. P. van Berge Henegouwen, Itta M. Minderhoud, Saskia W. C. van Mil, Herma H. Fidder, Gerard Dijkstra and Karel J. van Erpecum and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Bas Oldenburg

200 papers receiving 7.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease

2011 656 citations Bas Oldenburg, M.E.I. Schipper et al. Gut profile →
Declining Risk of Colorectal Cancer in Inflammatory Bowel Disease

2013 371 citations Maurice Lutgens, Bas Oldenburg et al. Inflammatory Bowel Diseases profile →

Peers

Countries citing papers authored by Bas Oldenburg

Since Specialization

Citations

This map shows the geographic impact of Bas Oldenburg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bas Oldenburg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bas Oldenburg more than expected).

Fields of papers citing papers by Bas Oldenburg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bas Oldenburg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bas Oldenburg. The network helps show where Bas Oldenburg may publish in the future.

Co-authorship network of co-authors of Bas Oldenburg

This figure shows the co-authorship network connecting the top 25 collaborators of Bas Oldenburg. A scholar is included among the top collaborators of Bas Oldenburg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bas Oldenburg. Bas Oldenburg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Food Compounds Associated With Disease Activity in Inflammatory Bowel Disease 2025 ·Inflammatory Bowel Diseases ·(unknown), Joost Westerhout, Marjolein Meijerink, Sabina Bijlsma, (unknown), Bas Oldenburg, Geert F. Houben	0
2	Fruits, Vegetables, Legumes, and Potatoes and Risk of Crohn's Disease and Ulcerative Colitis 2025 ·The American Journal of Gastroenterology ·Antoine Meyer, Franck Carbonnel, Christina C. Dahm, Jytte Halkjær, Anne Tjønneland, Matthias B. Schulze, Carlotta Sacerdote, Rosario Tumino, Bas Oldenburg, José María Huerta, Marcela Guevara, Dagfinn Aune, Marc J. Gunter, Alicia K. Heath, Paolo Vineis, Tammy Y. N. Tong, Aurélien Amiot, Simon Chan	0
3	OP15 High-definition white light endoscopy with segmental re-inspection is non-inferior compared to dye-based chromoendoscopy in Inflammatory Bowel Disease: the randomized controlled HELIOS trial 2024 ·Journal of Crohn s and Colitis ·(unknown), (unknown), Nathan den Broeder, Debora de Jong, (unknown), Marjolijn Duijvestein, Herma H. Fidder, (unknown), Meike M. Hirdes, Andrea E. van der Meulen‐de Jong, (unknown), Philip W. Voorneveld, Nanne K.H. de Boer, Charlotte P. Peters, Bas Oldenburg, Frank Hoentjen	4
4	Smoking and colorectal neoplasia in patients with inflammatory bowel disease: Dose‐effect relationship 2023 ·United European Gastroenterology Journal ·(unknown), Sjoerd G. Elias, Evelien Dekker, Herma H. Fidder, Frank Hoentjen, Joren R. ten Hove, Jeroen Maljaars, Andrea E. van der Meulen‐de Jong, Erik Mooiweer, (unknown), (unknown), Cyriel Y. Ponsioen, Fiona D M van Schaik, Bas Oldenburg, (unknown)	3
5	Toxicity-specific peripheral blood T and B cell dynamics in anti-PD-1 and combined immune checkpoint inhibition 2023 ·Cancer Immunology Immunotherapy ·(unknown), Rik J. Verheijden, (unknown), Stefan Nierkens, Anne S. R. van Lindert, Karijn P.M. Suijkerbuijk, Femke van Wijk, Linde Meyaard, Jürgen Kuball, Bas Oldenburg, Jeanette H.W. Leusen	15
6	Endoscopic management of patients with high-risk colorectal colitis–associated neoplasia: a Delphi study 2022 ·Gastrointestinal Endoscopy ·(unknown), Eduardo Albéniz, James E. East, Nayantara Coelho‐Prabhu, Noriko Suzuki, Yutaka Saito, Takayuki Matsumoto, Rupa Banerjee, Michał F. Kamiński, Ralf Kießlich, Emmanuel Coron, Annemarie C. de Vries, C. Janneke van der Woude, Raf Bisschops, Ailsa Hart, (unknown), Mathieu Pioche, Leon M.G. Moons, Bas Oldenburg	10
7	Chromogranin A regulates gut permeability via the antagonistic actions of its proteolytic peptides 2021 ·Acta Physiologica ·Elke M. Muntjewerff, Kechun Tang, (unknown), Gustaf Christoffersson, (unknown), Hong Gao, Gajanan D. Katkar, Soumita Das, Martin ter Beest, Wei Ying, Pradipta Ghosh, Sahar El Aidy, Bas Oldenburg, Geert van den Bogaart, Sushil K. Mahata	19
8	Monitoring a Combination of Calprotectin and Infliximab Identifies Patients With Mucosal Healing of Crohn’s Disease 2019 ·Clinical Gastroenterology and Hepatology ·Erwin Dreesen, Filip Baert, David Laharie, Peter Bossuyt, Yoram Bouhnik, Anthony Buisson, Guy Lambrecht, Édouard Louis, Bas Oldenburg, Benjamin Pariente, Marieke Pierik, C. Janneke van der Woude, Geert D’Haens, Séverine Vermeire, Ann Gils	60
9	Systematic Review and External Validation of Prediction Models Based on Symptoms and Biomarkers for Identifying Endoscopic Activity in Crohn's Disease 2019 ·Clinical Gastroenterology and Hepatology ·Eelco C. Brand, Sjoerd G. Elias, Itta M. Minderhoud, (unknown), Filip J. Baert, David Laharie, Peter Bossuyt, Yoram Bouhnik, Anthony Buisson, Guy Lambrecht, Édouard Louis, Benjamin Pariente, Marieke Pierik, C. Janneke van der Woude, Geert D’Haens, Séverine Vermeire, Bas Oldenburg	19
10	Off‐label prescriptions of drugs used for the treatment of Crohn’s disease or ulcerative colitis 2019 ·Alimentary Pharmacology & Therapeutics ·Melek Simsek, Birgit I. Lissenberg‐Witte, (unknown), (unknown), Frank Hoentjen, Bas Oldenburg, Cyriel Y. Ponsioen, C. Janneke van der Woude, Andrea E. van der Meulen‐de Jong, Marieke Pierik, Gerard Dijkstra, Nanne K.H. de Boer	3
11	Association Between Indefinite Dysplasia and Advanced Neoplasia in Patients With Inflammatory Bowel Diseases Undergoing Surveillance 2019 ·Clinical Gastroenterology and Hepatology ·(unknown), Shailja C. Shah, Joana Torres, Daniel Castañeda, (unknown), (unknown), Akash Kumar, Jordan E. Axelrad, Noam Harpaz, Thomas Ullman, Jean‐Frédéric Colombel, Bas Oldenburg, Steven H. Itzkowitz	24
12	High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease 2018 ·Clinical Gastroenterology and Hepatology ·Shailja C. Shah, Joren R. ten Hove, Daniel Castañeda, Carolina Palmela, Erik Mooiweer, Jean‐Frédéric Colombel, Noam Harpaz, Thomas Ullman, Ad A. van Bodegraven, Jeroen M. Jansen, Nofel Mahmmod, Andrea E. van der Meulen‐de Jong, Cyriel Y. Ponsioen, C. Janneke van der Woude, Bas Oldenburg, Steven H. Itzkowitz, Joana Torres	73
13	No Association Between Pseudopolyps and Colorectal Neoplasia in Patients With Inflammatory Bowel Diseases 2018 ·Gastroenterology ·(unknown), Shailja C. Shah, Joren R. ten Hove, Joana Torres, Erik Mooiweer, Daniel Castañeda, (unknown), (unknown), Akash Kumar, Jordan E. Axelrad, Thomas Ullman, Jean‐Frédéric Colombel, Bas Oldenburg, Steven H. Itzkowitz	54
14	Treatment of bone loss in osteopenic patients with Crohn's disease: a double-blind, randomised trial of oral risedronate 35 mg once weekly or placebo, concomitant with calcium and vitamin D supplementation 2013 ·Gut ·Adriaan A. van Bodegraven, Nathalie Bravenboer, Birgit I. Lissenberg‐Witte, Gerard Dijkstra, C. Janneke van der Woude, (unknown), Maurice G. Rüssel, Bas Oldenburg, Marieke Pierik, Jan C. Roos, R. A. van Hogezand, Vincent K. Dik, (unknown), J. C. Netelenbos, (unknown), Daniël W. Hommes, Paul Lips	18
15	Care seeking, use of complementary therapies and self management among people with type 2 diabetes and cardiovascular disease 2012 ·Victoria University Research Repository (Victoria University) ·Lenore Manderson, Rachel Canaway, (unknown), Bas Oldenburg, Vivian Lin, Bruce Hollingsworth, Maximilian de Courten	2
16	The economics of mesalazine in active ulcerative colitis and maintenance in the Netherlands. 2012 ·PubMed ·Mark P. Connolly, Cornelis Boersma, Bas Oldenburg	6
17	Risk of malignant lymphoma in patients with inflammatory bowel diseases: A Dutch nationwide study 2010 ·Inflammatory Bowel Diseases ·Anne Christine W. Vos, (unknown), Robert C. Minnee, (unknown), Dirk J. de Jong, Gerard Dijkstra, Pieter Stokkers, Ad A. van Bodegraven, (unknown), C. Janneke van der Woude, Bas Oldenburg, Daniël W. Hommes	74
18	C-reactive protein levels during a relapse of Crohn’s disease are associated with the clinical course of the disease 2008 ·World Journal of Gastroenterology ·(unknown), Matthijs P. Schwartz, Melvin Samsom, Bas Oldenburg	37
19	[British and American screening guidelines inadequate for prevention of colorectal carcinoma in patients with inflammatory bowel disease]. 2007 ·PubMed ·F.P. Vleggaar, Maurice Lutgens, Bas Oldenburg, M.E.I. Schipper, Melvin Samsom	5
20	Infliximab use in patients with Crohn's disease: quality of life, costs and resource use. 2006 ·PubMed ·(unknown), A.J.P. Schrijvers, Bas Oldenburg	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact